SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

Correspondence Activity Detail

Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083) (SNOA)
Activity window: Oct. 25, 2025 to Oct. 24, 2026

Back View Correspondence Compare Probe Scores Download Probe Score CSV

Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.

Probe Score Breakdown

Current total
2.5 / 10
Correspondence-letter component
1.0
AI sentiment component
1.5
Keyword-match component
0.0
Signal-match component
0.0
Notable 8-K modifier
0.0

The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Apr. 22, 2026. These dates describe different events.

Correspondence Filings
1
Keyword Matches
0
Latest Activity
Apr. 22, 2026
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Apr. 22, 2026 CORRESP Neutral/Informational High Sonoma Pharmaceuticals, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-1/A, which was filed on April 22, 2026. The company … Read Filing EDGAR
Apr. 22, 2026 CORRESP Neutral/Informational Moderate The correspondence from Dawson James Securities, Inc. to the SEC requests the effective date for Sonoma Pharmaceuticals, Inc.'s Registration Statement on Form S-1/A to be declared… Read Filing EDGAR
Apr. 10, 2026 UPLOAD Neutral/Informational Low The SEC has communicated to Sonoma Pharmaceuticals, Inc. that they do not intend to review the company's draft registration statement submitted on April 9, 2026. The SEC has reque… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.